Safety Assessment of Budesonide/Formoterol: Real-World Pharmacovigilance Analysis Using the FAERS, JADER, and CVAR Databases

Key Points

• Safety assessments reveal a notable incidence of adverse events associated with budesonide and formoterol.
• Analysis of the FAERS, JADER, and CVAR databases highlighted 125 serious adverse events in a large sample.
• Pharmacovigilance analysis leverages data from multiple databases to strengthen safety monitoring.
• Findings suggest ongoing surveillance is critical for patient safety regarding respiratory treatment options.